MMSI
Price
$94.00
Change
+$2.60 (+2.84%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.46B
7 days until earnings call
Intraday BUY SELL Signals
SYK
Price
$307.08
Change
+$9.48 (+3.19%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
114.15B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MMSI vs SYK

MMSI vs SYK Comparison Chart in %
View a ticker or compare two or three
VS
MMSI vs. SYK commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMSI is a StrongBuy and SYK is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MMSI with price predictions
Oct 21, 2026

MMSI in upward trend: price rose above 50-day moving average on October 15, 2026

MMSI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on MMSI as a result. In 63 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

The Moving Average Convergence Divergence (MACD) for MMSI just turned positive on October 12, 2026. Looking at past instances where MMSI's MACD turned positive, the stock continued to rise in 25 of 36 cases over the following month. The odds of a continued upward trend are 69%.

The 10-day moving average for MMSI crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where MMSI advanced for three days, in 197 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MMSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

MMSI broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MMSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.249) is normal, around the industry mean (4.952). P/E Ratio (37.306) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (1.574) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.273) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 75 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MMSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I.Advisor
a Summary for SYK with price predictions
Oct 21, 2026

SYK in upward trend: price rose above 50-day moving average on October 20, 2026

SYK moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SYK as a result. In 54 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.

The Moving Average Convergence Divergence (MACD) for SYK just turned positive on September 28, 2026. Looking at past instances where SYK's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.

Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYK advanced for three days, in 171 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

The 10-day RSI Indicator for SYK moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 20 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

SYK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SYK entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.759) is normal, around the industry mean (2.923). P/E Ratio (30.586) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

FUNDAMENTALS RATINGS
MMSI vs SYK: Fundamental Ratings
MMSI
SYK
OUTLOOK RATING
1..100
3737
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
7581
SMR RATING
1..100
7452
PRICE GROWTH RATING
1..100
3950
P/E GROWTH RATING
1..100
5681
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMSI's Valuation (75) in the Medical Specialties industry is in the same range as SYK (75). This means that MMSI’s stock grew similarly to SYK’s over the last 12 months.

MMSI's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as SYK (81). This means that MMSI’s stock grew similarly to SYK’s over the last 12 months.

SYK's SMR Rating (52) in the Medical Specialties industry is in the same range as MMSI (74). This means that SYK’s stock grew similarly to MMSI’s over the last 12 months.

MMSI's Price Growth Rating (39) in the Medical Specialties industry is in the same range as SYK (50). This means that MMSI’s stock grew similarly to SYK’s over the last 12 months.

MMSI's P/E Growth Rating (56) in the Medical Specialties industry is in the same range as SYK (81). This means that MMSI’s stock grew similarly to SYK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MMSISYK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
57%
Bearish Trend 9 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
41%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (MMSI: $91.40 vs. SYK: $297.60)
Brand notoriety: MMSI and SYK are both not notable
MMSI represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: MMSI: 101% vs. SYK: 89%
Market capitalization -- MMSI: $5.46B vs. SYK: $114.15B
MMSI [@Pharmaceuticals: Other] is valued at $5.46B. SYK’s [@Medical/Nursing Services] market capitalization is $114.15B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $151.25B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMSI’s FA Score shows that 0 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).

  • MMSI’s FA Score: 0 green, 5 red.
  • SYK’s FA Score: 0 green, 5 red.
According to our system of comparison, both MMSI and SYK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MMSI’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • MMSI’s TA Score: 5 bullish, 3 bearish.
  • SYK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MMSI is a better buy in the short-term than SYK.

Price Growth

MMSI (@Pharmaceuticals: Other) experienced а +4.86% price change this week, while SYK (@Medical/Nursing Services) price change was +5.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.63%. For the same industry, the average monthly price growth was -3.82%, and the average quarterly price growth was +8.73%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.68%. For the same industry, the average monthly price growth was -10.85%, and the average quarterly price growth was -10.57%.

Reported Earning Dates

MMSI is expected to report earnings on Oct 29, 2026.

SYK is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.68% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
MMSI
Daily Signal:
Gain/Loss:
SYK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MMSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMSI
1D Price
Change %
MMSI100%
+0.24%
BSX - MMSI
56%
Loosely correlated
-2.35%
SYK - MMSI
50%
Loosely correlated
-2.23%
ICUI - MMSI
50%
Loosely correlated
-0.15%
BDX - MMSI
44%
Loosely correlated
+0.28%
A - MMSI
43%
Loosely correlated
+2.74%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-2.23%
ISRG - SYK
65%
Loosely correlated
-2.26%
MDT - SYK
58%
Loosely correlated
-1.69%
A - SYK
56%
Loosely correlated
+2.74%
ALC - SYK
54%
Loosely correlated
-0.59%
MTD - SYK
54%
Loosely correlated
+2.69%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UPRO152.012.43
+1.62%
ProShares UltraPro S&P500 (UPRO)
DADS18.710.11
+0.59%
Digital Asset Debt Strategy ETF (DADS)
IGLD20.060.03
+0.15%
FT Vest Gold Strategy Target Income ETF (IGLD)
CPSA28.230.03
+0.09%
Calamos S&P 500 Structured Alt Protection ETF August (CPSA)
GPRF47.78-0.14
-0.29%
Goldman Sachs Access U.S. Preferred Stock and Hybrid Securities ETF (GPRF)